Drug Profile
Research programme: taxanes - Taxolog
Alternative Names: TL-1836; TL-1892Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Taxolog
- Class Taxanes
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (PO)
- 16 Apr 2008 Preclinical trials in Cancer in USA (PO)